Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Human Psychopharmacology Clinical and Experimental (2021) Vol. 37, Iss. 1
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

An insight review on the neuropharmacological effects, mechanisms of action, pharmacokinetics and toxicity of mitragynine
Nur Aisyah Khairul Annuar, Ummi Kalthum Azlan, Ahmed Mediani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116134-116134
Open Access | Times Cited: 8
Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 317-334
Open Access | Times Cited: 17
The Effects of Nigella Sativa (Black Seed) in Rhinosinusitis Subjects: A Systematic Review
Muhamad Najmi Muhamad Najemudin, Muhamad Zafran Anas Mahmood, Syahrir Zaini, et al.
Journal of Pharmacy (2025) Vol. 5, Iss. 1, pp. 132-155
Open Access
Effects of kratom alkaloids on mesolimbic dopamine release
James P Manus, Rebecca C Crenshaw, Lindsay C Ringer, et al.
Neuroscience Letters (2025), pp. 138153-138153
Closed Access
Modulatory effects of Kratom extract on the gut microbiota of rats: implications for health
Nattaya Thongsepee, Sumet Amonyingcharoen, Pholasit Chamod, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access
Inhibition of α-Glucosidase and Pancreatic Lipase Properties of Mitragyna speciosa (Korth.) Havil. (Kratom) Leaves
Thanchanok Limcharoen, Phisit Pouyfung, Ngamrayu Ngamdokmai, et al.
Nutrients (2022) Vol. 14, Iss. 19, pp. 3909-3909
Open Access | Times Cited: 20
Mitragyna Species as Pharmacological Agents: From Abuse to Promising Pharmaceutical Products
Islamudin Ahmad, Wisnu Cahyo Prabowo, Muhammad Arifuddin, et al.
Life (2022) Vol. 12, Iss. 2, pp. 193-193
Open Access | Times Cited: 18
Metabolic engineering of yeast for de novo production of kratom monoterpene indole alkaloids
M Holtz, Daniela Rago, Ida Nedermark, et al.
Metabolic Engineering (2024) Vol. 86, pp. 135-146
Closed Access | Times Cited: 3
Design, synthesis and biological evaluation of piperine derivatives as potent antitumor agents
Xiujun Wang, Yue Qiao, XiaoShuo Wang, et al.
Fitoterapia (2024) Vol. 177, pp. 106118-106118
Closed Access | Times Cited: 2
An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021
Xiaotong Li, Patrick Ndungu, Sanya B. Taneja, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 6, pp. 1002-1011
Open Access | Times Cited: 6
A Preliminary Inventory of Kratom (Mitragyna Speciosa) Products and Vendors on the Darknet and Cryptomarkets
Elisabeth Prevete, Valeria Catalani, Darshan Singh, et al.
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 4, pp. 485-495
Closed Access | Times Cited: 4
Design, Synthesis and Biological Evaluation of Piperine Derivatives as Potent Antitumor Agents
Xiu Jun Wang, Yue Qiao, XiaoShuo Wang, et al.
(2024)
Closed Access | Times Cited: 1
Kratom: Substance of Abuse or Therapeutic Plant?
David A. Gorelick
Psychiatric Clinics of North America (2022) Vol. 45, Iss. 3, pp. 415-430
Closed Access | Times Cited: 6
Drug testing for mitragynine and kratom: Analytical challenges and medico‐legal considerations
Anders Helander, Alexia Rylski
Drug Testing and Analysis (2022) Vol. 15, Iss. 2, pp. 213-219
Open Access | Times Cited: 6
Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder – a narrative review
Alexandra Arenson, Cynthia I. Campbell, Ilan Remler
Journal of Addictive Diseases (2023) Vol. 42, Iss. 3, pp. 253-263
Closed Access | Times Cited: 3
Kratom Alkaloids, Cannabinoids, and Chronic Pain: Basis of Potential Utility and Role in Therapy
Daniel Farkas, Ziva D. Cooper, Laila N. Heydari, et al.
Cannabis and Cannabinoid Research (2023)
Closed Access | Times Cited: 3
Kratom use disorder and unfolded protein response: Evaluating their relationship in a case control study
Bin Yang, Ming Tan, Ruiling Zhang, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0287466-e0287466
Open Access | Times Cited: 2
Evaluation of Antibacterial, Antibiofilm, Antioxidant, and Anti-Inflammatory Activities of Kratom Leaves (Mitragyna speciosa) Fermentation Supernatant Containing Lactobacillus rhamnosus GG
Phoomjai Sornsenee, Siriphorn Chimplee, Chonticha Romyasamit
Probiotics and Antimicrobial Proteins (2023)
Closed Access | Times Cited: 2
Narrative Review of Kratom, an Emerging Psychoactive Substance With Perianesthetic Implications
Emily H. Garmon, Kandice Olson
Anesthesia & Analgesia (2022)
Closed Access | Times Cited: 3
Metabolic engineering of yeast forde novoproduction of kratom monoterpene indole alkaloids
M Holtz, Daniela Rago, Ida Nedermark, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Design, Synthesis and Biological Evaluation of Piperine Derivatives as Potent Antitumor Agents
Xiu Jun Wang, Yue Qiao, XiaoShuo Wang, et al.
(2024)
Closed Access
Kratom (<i>Mitragyna speciosa</i>) Use and Mental Health: A Systematic Review and Multilevel Meta-Analysis
Yuting Yang, Christian P. Müller, Darshan Singh
European Addiction Research (2024) Vol. 30, Iss. 4, pp. 252-274
Closed Access
Important factors associated with using kratom among the U. S. population aged 12 years and above in 2019
Suraj Dhankikar, Akansha Arewar, Megan Quinn, et al.
International Journal of Basic & Clinical Pharmacology (2024) Vol. 13, Iss. 5, pp. 605-611
Open Access
Use Patterns of Classic, Novel, and Herbal Opioids
Elisabeth Prevete, Natasha L. Mason, Kim P. C. Kuypers, et al.
Emerging Trends in Drugs Addictions and Health (2024), pp. 100166-100166
Open Access
Page 1 - Next Page

Scroll to top